Nan Shan Life Insurance’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.1M Sell
61,464
-3,400
-5% -$282K 0.11% 96
2025
Q1
$5.26M Hold
64,864
0.12% 93
2024
Q4
$5.84M Hold
64,864
0.14% 88
2024
Q3
$6.41M Hold
64,864
0.15% 76
2024
Q2
$6.01M Sell
64,864
-160
-0.2% -$14.8K 0.14% 86
2024
Q1
$6.17M Sell
65,024
-3,880
-6% -$368K 0.15% 86
2023
Q4
$6.15M Sell
68,904
-6,850
-9% -$612K 0.15% 81
2023
Q3
$5.53M Sell
75,754
-2,400
-3% -$175K 0.15% 79
2023
Q2
$6.5M Sell
78,154
-4,400
-5% -$366K 0.16% 84
2023
Q1
$6.29M Sell
82,554
-3,738
-4% -$285K 0.15% 84
2022
Q4
$7.16M Sell
86,292
-2,700
-3% -$224K 0.2% 75
2022
Q3
$7.06M Buy
88,992
+2,600
+3% +$206K 0.17% 81
2022
Q2
$6.42M Buy
86,392
+2,238
+3% +$166K 0.13% 85
2022
Q1
$7.56M Sell
84,154
-868
-1% -$78K 0.13% 81
2021
Q4
$9.52M Hold
85,022
0.14% 86
2021
Q3
$10.7M Hold
85,022
0.18% 86
2021
Q2
$11.5M Buy
85,022
+33,200
+64% +$4.5M 0.19% 89
2021
Q1
$7.03M Buy
51,822
+9,822
+23% +$1.33M 0.14% 104
2020
Q4
$5.91M Sell
42,000
-12,226
-23% -$1.72M 0.12% 108
2020
Q3
$6.04M Buy
+54,226
New +$6.04M 0.16% 90
2020
Q2
Sell
-12,300
Closed -$953K 116
2020
Q1
$953K Hold
12,300
0.03% 91
2019
Q4
$1.17M Sell
12,300
-3,051
-20% -$290K 0.04% 86
2019
Q3
$1.17M Hold
15,351
0.03% 83
2019
Q2
$1.35M Hold
15,351
0.03% 88
2019
Q1
$1.39M Hold
15,351
0.03% 99
2018
Q4
$1.1M Sell
15,351
-4,900
-24% -$351K 0.03% 103
2018
Q3
$1.94M Sell
20,251
-10,049
-33% -$963K 0.04% 99
2018
Q2
$2.88M Sell
30,300
-39,900
-57% -$3.8M 0.07% 89
2018
Q1
$6.16M Buy
+70,200
New +$6.16M 0.13% 83